Cargando…

Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma

Detalles Bibliográficos
Autores principales: Sun, Yanfei, Mu, Guangjing, Xue, Zhiwei, Li, Xingang, Lin, Xiaoying, Han, Mingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308772/
https://www.ncbi.nlm.nih.gov/pubmed/37386497
http://dx.doi.org/10.1186/s12967-023-04185-5
_version_ 1785066317611532288
author Sun, Yanfei
Mu, Guangjing
Xue, Zhiwei
Li, Xingang
Lin, Xiaoying
Han, Mingzhi
author_facet Sun, Yanfei
Mu, Guangjing
Xue, Zhiwei
Li, Xingang
Lin, Xiaoying
Han, Mingzhi
author_sort Sun, Yanfei
collection PubMed
description
format Online
Article
Text
id pubmed-10308772
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103087722023-06-30 Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma Sun, Yanfei Mu, Guangjing Xue, Zhiwei Li, Xingang Lin, Xiaoying Han, Mingzhi J Transl Med Letter to the Editor BioMed Central 2023-06-29 /pmc/articles/PMC10308772/ /pubmed/37386497 http://dx.doi.org/10.1186/s12967-023-04185-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Sun, Yanfei
Mu, Guangjing
Xue, Zhiwei
Li, Xingang
Lin, Xiaoying
Han, Mingzhi
Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma
title Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma
title_full Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma
title_fullStr Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma
title_full_unstemmed Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma
title_short Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma
title_sort pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308772/
https://www.ncbi.nlm.nih.gov/pubmed/37386497
http://dx.doi.org/10.1186/s12967-023-04185-5
work_keys_str_mv AT sunyanfei pharmacologicaltargetingofonecarbonmetabolismasanoveltherapeuticstrategyforglioblastoma
AT muguangjing pharmacologicaltargetingofonecarbonmetabolismasanoveltherapeuticstrategyforglioblastoma
AT xuezhiwei pharmacologicaltargetingofonecarbonmetabolismasanoveltherapeuticstrategyforglioblastoma
AT lixingang pharmacologicaltargetingofonecarbonmetabolismasanoveltherapeuticstrategyforglioblastoma
AT linxiaoying pharmacologicaltargetingofonecarbonmetabolismasanoveltherapeuticstrategyforglioblastoma
AT hanmingzhi pharmacologicaltargetingofonecarbonmetabolismasanoveltherapeuticstrategyforglioblastoma